Menu
No results found.
BAVA
Bavarian Nordic A/S – CPH
“Patience reduces risk more reliably than prediction.”
Weekly Share Price & Valuation Overview
Market Overview
Open
236.7000
Close
236.6000
High
237.6000
Low
236.6000
Trend
0.80756
Bavarian Nordic A/S
Denmark
• CPH - Copenhagen Stock Exchange
• BAVA
• Currency: DKK
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Key strengths
- Growth + profitability: double-digit revenue and profit margins.
- Healthy operating margin (≥15%) indicates efficient core operations.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Double-digit profit margin (≥10%) supports robust bottom-line economics.
- Revenue growth ≥10% indicates solid top-line momentum.
- Earnings growth ≥10% supports improving profitability trajectory.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
Potential weaknesses
- Negative free cash flow — operations may rely on external financing.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- DKK 18.57B
- Enterprise Value Operating value: market cap + total debt − cash.
- DKK 16.96B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- DKK 6.46B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- DKK 3.43B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- DKK 2.15B
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- DKK 81.86
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 17.99
- Shares Outstanding
- 78.24M
- Float Shares
- 77.68M
- Implied Shares Outstanding
- 77.99M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
22.46%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
33.28%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
53.10%
- Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).
-
22.04%
- ROA Return on assets: net income ÷ total assets.
-
6.88%
- ROE Return on equity: net income ÷ shareholder equity.
-
12.65%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Strong Year-over-year revenue growth.
-
15.70%
- Earnings Growth (YoY) Strong Year-over-year earnings growth.
-
36.40%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
38.80%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.58
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 1.13
- Total Cash Cash and equivalents.
- DKK 1.66B
- Total Debt Short + long-term interest-bearing debt.
- DKK 136.05M
- Net Debt Net Cash Total debt − cash (negative = net cash).
- DKK -1.53B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 0.06
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- DKK 1.77B
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- DKK -3.20B
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
27.37%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-49.64%
- Cash Conversion (OpCF/EBITDA)
- 0.82
Sharemaestro House View
Confidence: 2
Sharemaestro internal conviction (0–3, higher is better).
Risk: 1
Sharemaestro internal risk profile (0–3, higher is safer).
Operational: 1
Operational quality/consistency (0–3, higher is better).
Composite Score: 3
Overall internal composite (0–3, higher is better).
Suggested Allocation: 5.00%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
99.3%
Insiders
Shares held by company insiders (officers, directors).
0.1%
Institutions
Shares held by institutions (funds, pensions).
30.7%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
None detected
Net Debt
Total debt − cash (negative = net cash).
DKK -1.53B
-23.7% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
87
Methodology Notes
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-09-09 12:42
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
Performance Edge:
Signals that work. Valuations that spot mispricing early. A disciplined, data-driven methodology powered by machine learning. Sharemaestro helps high-net-worth investors, hedge funds, family offices, and institutions move sooner - and with conviction - when the market presents asymmetric opportunity.
Subscribe to Sharemaestro: